Design - Prospective observational inhaled steroid withdrawal study. 45 Dutch general practices. Participants - 232 subjects with a general practice based diagnosis of COPD with various degrees of ...

Marketed in the past by AstraZeneca as Pulmicort, budesonide is an off-patent inhaled steroid and could be used ... with asthma or chronic obstructive pulmonary disease (COPD) were surprisingly ...

The current model for managing chronic obstructive pulmonary disease (COPD) generally considers inhalers from the same therapeutic class to be clinically equivalent.1 When a long-acting muscarinic ...

Current guidelines recommend the use of inhaled corticosteroids (ICSs) added to long-acting β 2-agonists (LABAs) for treatment of symptomatic patients with severe and very severe COPD.

Immunoglobulin G hypogammaglobulinemia was found in 44.7% of patients with acute exacerbations of COPD receiving triple ...

Many patients on steroids fail treatment ... and you see no improvement in your symptoms after using an inhaler." COPD is a long-term lung condition in which the airways become damaged or blocked ...

"Today's results are significant as they show for the first time the positive effect of directly switching to Ultibro Breezhaler from other COPD treatments, such as inhaled steroid-containing ...

Professor David Denning evaluates timely and accurate diagnosis of Aspergillus infection and the clinical spectrum of ...

Inhaled and oral corticosteroids do not inhibit leukotriene ... may detect leukotriene-driven inflammation in those with COPD or ACOS. Two 'real-world' clinical trials evaluated LTRA as first ...

Patients with COPD had better inhaler adherence when invited to enroll in a program that lowers cost sharing for maintenance inhalers and offers medication management services, according to results ...

A new study published in the CHEST journal found that ensifentrine, an innovative inhaled therapy, significantly reduces the ...